TheraPanacea in the news
AI healthcare clinical solutions
Tamtam found 18 recent articles about TheraPanacea.
- TheraPanacea : l’automatisation intelligente et personnalisée de la radiothérapie
TheraPanacea develops AI-driven software to automate and personalize radiotherapy treatments for cancer patients globally.
- Top 5 AI Tools for Radiation Oncologists: What Clinicians Need to Know
Modern AI tools are automating radiation oncology workflows, enabling real-time adaptive treatment and more precise tumor targeting to improve patient outcomes.
- L’export, voie royale pour la pépite santé TheraPanacea
AI-driven software optimizes radiotherapy precision and automates clinical workflows to improve cancer treatment outcomes globally.
- TheraPanacea révolutionne la radiothérapie grâce à l'IA
TheraPanacea uses artificial intelligence to improve radiotherapy precision and reduce treatment side effects for cancer patients.
- TheraPanacea, la start-up qui ajoute de l'IA dans la radiothérapie
TheraPanacea is expanding its AI-driven radiotherapy software into the Japanese market following recent regulatory approval.
- Biogen et la pépite TheraPanacea misent sur l'IA pour améliorer le diagnostic de la sclérose en plaques
Biogen is investing 49.3 million euros in TheraPanacea to develop AI-driven imaging software for predicting the progression of neurological diseases like Multiple Sclerosis.
- Biogen puts $15m into digital health alliance with TheraPanacea
Biogen is investing $15 million in TheraPanacea to use AI and machine learning for improving neuroscience drug development and patient care.
- Biogen & TheraPanacea Join Forces to Advance Digital Health Solutions
Biogen has partnered with TheraPanacea to develop AI-powered digital health solutions for neuroscience, involving a $15 million debt acquisition and potential $41 million in milestone payments.
- Biogen and TheraPanacea Announce New Collaboration with the Potential to Advance Digital Health for Personalized Medicine in Neuroscience
Biogen is investing over $50 million in a collaboration with TheraPanacea to use AI-driven healthcare solutions for personalized medicine in neuroscience.
- Des outils d'IA pour personnaliser la radiothérapie du glioblastome
A consortium led by TheraPanacea and GE Healthcare is developing AI-driven personalized radiotherapy solutions for glioblastoma patients.
- Therapanacea develops AI solution to quantify the severity of lung damage from COVID-19
Therapanacea is partnering with healthcare and tech leaders to create a COVID-19 database and AI tools for lung damage assessment.
- GE Healthcare, Orange Healthcare et TheraPanacea collaborent avec l’AP-HP et la Société d’Imagerie Thoracique pour créer une base de données inédite sur le COVID-19
A collaboration between healthcare and tech leaders to build a massive database of 10,000 CT scans for AI-driven COVID-19 pneumonia diagnosis.
- TheraPanacea, intelligent, personalised automation of radiotherapy
TheraPanacea develops AI-powered software to automate and personalize radiotherapy, aiming to improve cancer treatment outcomes and accessibility.
- TheraPanacea transforme les maths et l'intelligence artificielle en armes anti-cancer
AI-driven software ART-Plan automates radiotherapy planning to drastically reduce preparation time and improve cancer treatment precision.
- TheraPanacea : l’automatisation intelligente et personnalisée de la radiothérapie
TheraPanacea develops AI software to automate and personalize radiotherapy, aiming for faster, more precise, and effective cancer treatments globally.
- TheraPanacea, lauréate du programme européen Horizon 2020 SME Instrument, obtient un financement de 2,5 millions d’euros
TheraPanacea secured 2.5 million euros in EU funding to develop and commercialize AI-driven, MRI-based radiotherapy planning software.
- Radiothérapie : rencontre avec Nikos Paragios, président cofondateur de TheraPanacea
TheraPanacea develops AI-driven software to automate radiotherapy treatments, reducing side effects and increasing the capacity of oncology departments.
- TheraPanacea cible un investisseur
TheraPanacea raised 3.5 million euros from Therinvest to optimize radiotherapy treatment through its software suite.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like TheraPanacea?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies